Versiti Launches New Test to Improve HIT Diagnostics, Reduce Progression to Deadly Conditions Caused by Thrombosis
- Monday, December 2, 2019, 8:24
- Environment
- Add a comment
MILWAUKEE, Dec. 2, 2019 /PRNewswire/ — Versiti, Inc., a national leader in blood health innovation, is excited to announce the launch of its new P-Selectin Expression Assay (PEA). The PEA was developed as the next evolution diagnostic option for patients suspected to have Heparin-Induced…
About the Author
adminasapcorp has written 39124 stories on this site.